Patent · US Active

Anti-TREM-2 agonist antibodies

US12145988B2 · kind B2 · utility

0Cited by
1References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 11, 2019
Grant dateNov 19, 2024
Priority date
Expiry dateFeb 19, 2042

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The present disclosure encompasses anti-TREM-2 antibodies that promote TREM-2 activation and methods of using the anti-TREM-2 agonist antibodies therapeutically.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.